Ultrasound-guided botulinum toxin type A injection to the iliopsoas muscle in the management of children with cerebral palsy

NeuroRehabilitation

Volumn 23, Issue 3, 2008, Pages 199-205

  Depedibi, R ^a,b   Unlu E ^a   Cevikol A ^a   Akkaya, T ^a   Cakci A ^a   Cerekci R ^a   Kose G ^a   Unlusoy D ^a  

^a MINISTRY OF HEALTH   (Turkey)

^b Clinic of Anesthesiology and Reanimation ^*  (Turkey)

Author keywords

Botulinum toxin a; Cerebral palsy; GMFM; Physical therapy; WeeFIM

Indexed keywords

BACLOFEN; BOTULINUM TOXIN A;

ARTICLE; CEREBRAL PALSY; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DISTANCE BETWEEN KNEE SCALE; DUNCAN ELY TEST; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL INDEPENDENCE MEASURE FOR CHILDREN; GROSS MOTOR FUNCTION MEASURE; HUMAN; ILIOPSOAS MUSCLE; MALE; MODIFIED ASHWORTH SCALE; MODIFIED PHYSICIAN RATING SCALE; MOTOR PERFORMANCE; PHYSIOTHERAPY; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANGE OF MOTION; RATING SCALE; SCHOOL CHILD; SELECTIVE MOTOR CONTROL SCALE; SPASTICITY; THOMAS TEST; TREATMENT RESPONSE; ULTRASOUND;

EID: 47849095942     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.3233/nre-2008-23301     Document Type: Article

References (41)

1. B. Anthony, Ward. Botulinum toxin type A treatment of hip and thigh spasticity :a technique for injection of psoas major muscle, Eur J Neurol 6(Suppl 4) (1999), 91-93.
2. R. Balkrishnan, J.C. Manuel, B.P. Smith, F.T. Camacho and L.A. Koman, Longitudinal examination of health outcomes associated with botulinum toxin use in children with cerebral palsy, J Surg Orthop Adv 13(2) (2004), 76-80.
3. S. Berweck and F. Heinen, Child and Brain, Treatment of cerebral palsy with botulinum toxin principles, clinical practice. Atlas, 78, 80.
4. S. Berweck, A. Feldkamp, A. Francke, J. Nehles, A. Schwerin and F. Heinen, Sonography-guided injection of botulinum toxin A in the children with cerebral palsy, Neuropediatrics 33 (2002), 221-223.
5. R. Boyd and H.K. Graham, Botulinum toxin A in the management of children with cerebral palsy: indications and outcome, Eur J Neurol 4(Suppl 2) (1997), 15-22.
6. R.N. Boyd, V. Pliatsios and H.K. Graham, Use of objective measures in predicting response to Botulinum toxin A in children with cerebral palsy, Dev Med Child Neurol 40(Suppl) (1998), 48.
7. R. Boyd and H. Graham, Objective measurement of clinical findings in the use of botulinum toxin-A for the management of children with CP, Eur J Neurol 6 (1999), 23-35.
8. G.R. Calderon, S.R.F. Calderon and R.M. Rincon, Botulinum toxin A in the management of cerebral palsy, Pediatr Neurology 10 (1994), 284-288.
9. E.B. Carpenter and D.G. Seitz, Intramuscular alcohol as an aid in management of spastic cerebral palsy, Dev Med Child Neurol 22 (1980), 497-501.
10. E.B. Carpenter, Role of nerve blocks in the foot and ankle in cerebral palsy: therapeutic and diagnostic, Foot Ankle 4(3) (Nov-Dec 1983), 164-166.
11. A.M. Chutorian and L. Root, Management of spasticity in children with Botulinum toxin, Int Pediatric 9(Suppl) (1994), 35-43.
12. A.P. Cosgrove and H.K. Graham, Botulinum toxin - A in the management of spasticity with cerebral palsy, Br J Surgery 74B (1992), 135-136.
13. K. Desloovere, G. Molenaers and J. De Cat, Physiotherapy and Tone Reduction Based on Gait Analysis, Pellenberg University Hospital, Leuven, Belgium.
14. M. Diamond, Rehabilitation strategies for the child with cerebral palsy, Pediatr Ann 15 (1986), 230-236.
15. J.O. Dolly, J. Black, R.S. Williams and J. Melling, Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization, Nature 307 (1984), 457-460.
16. N.W. Eames, R. Baker, A. Hill, H.K. Graham and A.P. Cosgrove, The effect of botulinum toxin A on gastrocnemius muscle length: magnitude and duration of response, Dev Med Child Neurol 41(4) (Apr 1999), 226-232.
17. M.A. El-Etribi, M.E. Salem and H.M. El-Shakankiry, The effect of botulinum toxin - a injection on spasticity, range of motion and gait patterns in children with spastic diplegic cerebral palsy, Int J Rehabil Res 27(4) (2004), 275-281.
18. P.J. Flett, L.M. Stern, H. Waddy et al., Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy, J Paediatr Child Health 35 (1999), 71-77.
19. H. Forssberg and K.B. Tedroff, Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation? Dev Med Child Neurol 39 (1997), 635-640.
20. A.M. Glanzman, H. Kim, K. Swaminathan and T. Beck, Efficacy of botulinum toxin A, serial casting, and combined treatment for spastic equinus: a retrospective analysis, Dev Med Child Neurol 46(12) (Dec 2004), 807-811.
21. L.A. Koman, J.F. Mooney, III., B.P. Smith, A. Goodman and T. Mulvaney, Management of cerebral palsy with botulinum A toxin, preliminary investigation, J Pediatr Orthop 13 (1993), 489-495.
22. J.A. Koman, J.F. Mooney, III. and B.P. Smith, Botulinum Toxin: Potential Role in the Management of Cerebral Palsy During Childhood, Therapy with Botulinum Toxin. New York: Marcel Dekker, 1994, 511-522.
23. J.A. Koman, J.F. Mooney, III., B.P. Smith et al., Botulinum toxin - a neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy, J Pediatr Orthop 20 (2000), 108-115.
24. L.A. Koman, A. Brashear and S. Rosenfeld, Botulinum toxin type A neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open label clinical trial, Pediatrics 108(5) (2001), 1062-1071.
25. J.W. Lance, Pathophysiology of spasticity and clinical experience of baclofen, in: Spasticity: Disordered Motor Control, R.G. Feldman, R.R. Young and W.P. Koella, eds, Chicago, IL: Year Book Medical, 1980, pp. 185-203.
26. M. Linder, G. Schindler, U. Michaelis, S. Stein, J. Kirschner, V. Mall, S. Berweck, R. Korinthenberg and F. Heinen, Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure, Eur J Neurol 8(Suppl 5) (Nov 2001), 120-126.
27. D.J. Mathews and P. Wilson, Cerebral palsy, in: Pediatric Rehabilitation, (3rd ed.), G.E. Molnar and M.A. Alexander, eds, Philadelphia, PA: Hanley & Belfus, 1999, pp. 193-217.
28. G. Molenaers, K. Desloovere, M. Eyssen, J. De Cat, I. Jonkers and P. De Code, Botulinum toxin type A treatment of cerebral palsy: an integrated approach, Eur J Neurol 6(Suppl 4) (1999), 51-57.
29. G. Molenaers, M. Eyssen, K. Desloovere, I. Jonkers and P. De Cock, A multilevel approach to botulinum toxin type A treatment of the iliopsoas in spasticity in cerebral palsy, Eur J Neurol 6 (1999), 59-62.
30. M.E. Msall, K.M. DiGaudio, B.T. Rogers et al., The Functional Independence Measure for Children (WeeFIM): conceptual basis and pilot use in children with developmental disabilities, Clin Pediatr 33 (1994), 421-430.
31. H. Oguz and N. Dursun, Tibbi Rehabilitasyon, Nobel Tip Kitapevleri, 2004, 67-82, 957-972, 729-736.
32. L.R. Robinson and A.D. Hillel, Botulinum toxin treatment for motor control disorders, Phys Med Rehabil Clin N Am 4 (1993), 731-744.
33. D. Russell, P. Rosenbaum, C. Gowland, S. Hardy, M. Lane and N. Plews, Gross Motor Function Measure Manual, (2nd ed.), Hamilton, Ontario, Canada: McMaster University; 1993.
34. B.S. Russman, A. Tilton and M.E.J. Gomley, Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin treatment, Muscle Nerve 6(Suppl) (1997), 181-193.
35. B. Sarioǧlu, G. Serdaroǧlu, S. Tütüncü oǧlu and E.A. Özer, The use of botulinum toxin type A treatment in children with spasticity, Pediatr Neurol 29(4) (2003), 299-301.
36. L.M. Stempien and D. Gaebler-Spira, Rehabilitation of children and adults with cerebral palsy, in: Handbook of Physical Medicine and Rehabilitation, R.L. Braddom, ed., Chapter 53, 1996, pp. 1113-1132.
37. A. Suputtitada, Managing spasticity in pediatric cerebral palsy using a very low dose of botulinum toxin type A: preliminary report, Am J Phys Med Rehabil 79(4) (Jul/Aug 2000), 320-326.
38. T. Ubhi, B.B. Bhakta, H.L. Ives, V. Allgar and S.H. Roussounis, Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy, Arch Dis Child 83(6) (Dec 2000), 481-487.
39. M.J. Willenborg, J.S. Shilt, B.P. Smith et al., Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum a toxin injection in cerebral palsy, J Pediatr Orthop 22(2) (2002), 165-168.
40. J. Wissel, F. Heinen, A. Schenken et al., Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment, Neuropediatrics 30 (1999), 120-124.
41. I. Ziv, N. Blackburn, M. Rang and J. Koreska, Muscle growth in normal and spastic mice, Dev Med Child Neurol 26 (1984), 94-99.